This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barletta GM and Bunchman TE (2004) Acute renal failure in children and infants. Curr Opin Crit Care 10: 499–504
Andreoli SP et al. (2002) Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17: 293–298
Trachtman H et al. (2003) Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA 290: 1337–1344
Friedman AL (2005) Pediatric hydration therapy: historical review and a new approach. Kidney Int 67: 380–388
Tzipori S et al. (2004) Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 17: 926–941
Acknowledgements
The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Trachtman, H. Does parenteral volume expansion improve outcomes in children infected with Escherichia coli O157:H7?. Nat Rev Nephrol 1, 14–15 (2005). https://doi.org/10.1038/ncpneph0024
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0024